benperidol has been researched along with Parkinsonian Disorders in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Checkoway, H; Criswell, SR; Lenox-Krug, J; Moerlein, SM; Perlmutter, JS; Racette, BA; Searles Nielsen, S; Sheppard, L; Warden, MN | 1 |
| Beu, M; Forutan, F; Larisch, R; Müller-Gärtner, HW; Nikolaus, S; Vosberg, H | 1 |
2 other study(ies) available for benperidol and Parkinsonian Disorders
| Article | Year |
|---|---|
Selective D2 receptor PET in manganese-exposed workers.
Topics: Adult; Aged; Benperidol; Brain; Case-Control Studies; Female; Humans; Male; Manganese; Manganese Poisoning; Middle Aged; Multimodal Imaging; Neuroimaging; Parkinsonian Disorders; Positron-Emission Tomography; Receptors, Dopamine D2; Young Adult | 2018 |
Bilateral increase in striatal dopamine D2 receptor density in the 6-hydroxydopamine-lesioned rat: a serial in vivo investigation with small animal PET.
Topics: Adaptation, Physiological; Animals; Benperidol; Feasibility Studies; Fluorine Radioisotopes; Male; Neostriatum; Oxidopamine; Parkinsonian Disorders; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Tissue Distribution; Tomography, Emission-Computed | 2003 |